The outlook for CBD products and the industrial hemp industry is bright. As the legal cannabis industry’s value rockets towards $22.8 billion by 2020, the market for hemp-based products is poised to grow 700% by the same year.
A large portion of this growth is predicted to be carried by CBD products, whose market share is expected to claim $2 billion by 2020, a steep increase in value compared to its 2017 valuation of $220 million. As the market climbs to billion-dollar status, so does the opportunity to diversify, innovate, and meet the growing demands of consumers.
One of the major drivers for the CBD market is the growing list of health benefits of CBD oil. Supported by an increase in scientific research, CBD oil products are now being used to treat numerous ailments in the human body. At AG Health, we match the growing demand for CBD oil products with an ongoing pursuit of more complete and effective products.
We call these products Endocannabinoid Nutrition (ECN) because of our belief that CBD is a healthy, natural part of human nutrition.